Your next-step guide
Reading summary
CAR-T is not an option for every cancer. Eligibility, product, and availability need confirmation from the hospital team.
Full transcript →← All guides
CAR-T: understand limits and the process
CAR-T is not an option for every cancer. Eligibility, product, and availability need confirmation from the hospital team.
Understand the topic
CAR-T uses T cells modified in a laboratory to recognise targets on cancer cells. Collection, laboratory processing, infusion, and monitoring are parts of the discussion with the clinical team.
Three things to discuss
Ask whether the diagnosis and previous treatments fit the product indication being discussed.
Ask about assessment stages, possible waiting time, and the plan if treatment cannot proceed.
Request an explanation of risks, monitoring, full costs, and follow-up after returning home.
Keep a preparation checklist
Check items for your family discussion. BKC does not send or store this list.
Educational video made from facility photos. Video and captions are Indonesian; a reading summary is available below the video.
Sources & information limits
BKC editorial guide, updated 22 October 2026. General information to prepare a conversation; not diagnosis, eligibility assessment, or treatment advice. Doctors and hospitals confirm each case.
Read the reference source ↗Keep exploring
You do not need to choose a hospital yet.
Start with the records you already have.